Industry Discovery & Development Partnership Program
Breakthrough T1D's IDDP Program funds for-profit research to develop innovative therapies and devices for type 1 diabetes that have strong scientific and commercial potential.
Funder: Breakthrough T1D
Due Dates: Rolling (LOIs and applications accepted year-round)
Funding Amounts: Budget and duration as approved; applicants must provide matching funds equal to or greater than the amount requested from Breakthrough T1D.
Summary: Supports for-profit companies developing therapeutics or devices for type 1 diabetes that align with Breakthrough T1D’s research priorities.
Key Information: Applicants must contact Breakthrough T1D before submitting a letter of intent; matching funds are required.
Description
The Industry Discovery & Development Partnership (IDDP) Program from Breakthrough T1D is designed to accelerate the development of impactful therapies and devices for type 1 diabetes (T1D) by supporting research in for-profit organizations. The program leverages the strengths of biotech, pharmaceutical, device companies, and other commercial entities to advance projects with high commercial potential, while providing access to Breakthrough T1D’s expertise and global leadership in T1D research and advocacy. Projects must be closely aligned with Breakthrough T1D’s priority research areas and demonstrate a clear path toward commercialization and meaningful impact for the T1D community.
